# Oric Pharmaceuticals, Inc.: Form SCHEDULE 13D, filed Jun 5, 2025

- Company: [Oric Pharmaceuticals, Inc.](/companies/oric.md) (CIK 1796280)
- Form: SCHEDULE 13D
- Filed: 2025-06-05
- Accepted by EDGAR: Jun 5, 2025, 21:17 ET
- Period: not reported
- Accession: 0000950170-25-082520
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1796280/000095017025082520/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1796280/000095017025082520/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1796280/000095017025082520/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 5, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-082520. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.